Kounis syndrome: Is ceftriaxone or metronidazole responsible for acute myocardial infarction? A rare case

Çakmak, Abdulkadir; Keskin, Gökhan

Journal Metrics

Impact Factor (2022): 1.3
5-Year Impact Factor: 1.5
Eigenfactor Score: 0.00148
CiteScore (2022): 1.9
SCImago Journal Rank: 0.29

28/4Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and institutes

In titles and abstracts

In keywords

In all

The Anatolian Journal of Cardiology

Kounis syndrome: Is ceftriaxone or metronidazole responsible for acute myocardial infarction? A rare case [Anatol J Cardiol]

Anatol J Cardiol. 2021; 25(6): 451-452 | DOI: 10.5152/AnatolJCardiol.2020.36422

Kounis syndrome: Is ceftriaxone or metronidazole responsible for acute myocardial infarction? A rare case

Abdulkadir Çakmak, Gökhan Keskin
Department of Cardiology, Faculty of Medicine, Amasya University; Amasya-Turkey

Keywords: Myocardial infarction, Metronidazole, Ceftriaxone, Kounis syndrome

Kounis sendromu: seftriakson mu metronidazol mu sorumlu - nadir bir vaka sunumu.

Abdulkadir Çakmak, Gökhan Keskin
Amasya Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Amasya, Türkiye

Anahtar Kelimeler: Miyokard enfarktüsü, Metronidazol, Seftriakson, Kounis sendromu

Abdulkadir Çakmak, Gökhan Keskin. Kounis syndrome: Is ceftriaxone or metronidazole responsible for acute myocardial infarction? A rare case. Anatol J Cardiol. 2021; 25(6): 451-452

Corresponding Author: Abdulkadir Çakmak, Türkiye
Manuscript Language: English

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar